Cargando…
Induction of Stem-Cell-Derived Cardiomyogenesis by Fibroblast Growth Factor 10 (FGF10) and Its Interplay with Cardiotrophin-1 (CT-1)
SIMPLE SUMMARY: Cardiovascular diseases are worldwide one of the leading contributors of mortality, and among multiple therapeutic approaches, stem cell therapy has been introduced as a robust therapeutic strategy to alleviate related symptoms and restore cardiac functions. Prior to this, however, f...
Autores principales: | Khosravi, Farhad, Ahmadvand, Negah, Wartenberg, Maria, Sauer, Heinrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026462/ https://www.ncbi.nlm.nih.gov/pubmed/35453733 http://dx.doi.org/10.3390/biology11040534 |
Ejemplares similares
-
The Multifunctional Contribution of FGF Signaling to Cardiac Development, Homeostasis, Disease and Repair
por: Khosravi, Farhad, et al.
Publicado: (2021) -
The Milk Thistle (Silybum marianum) Compound Silibinin Inhibits Cardiomyogenesis of Embryonic Stem Cells by Interfering with Angiotensin II Signaling
por: Ali, Enas Hussein, et al.
Publicado: (2018) -
Role of cardiotrophin-1 in obesity and insulin resistance
por: Moreno-Aliaga, María J., et al.
Publicado: (2012) -
Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression
por: Miteva, Kapka, et al.
Publicado: (2020) -
Increased Expression of Cardiotrophin-1 in Cardiomyopathy Patients
por: Sharif, S, et al.
Publicado: (2021)